- Home
- CLDX vs BXMT Comparison
CLDX vs BXMT Comparison
Compare CLDX & BXMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- BXMT
- Stock Information
- Founded
- CLDX 1983
- BXMT 1966
- Country
- CLDX United States
- BXMT United States
- Employees
- CLDX N/A
- BXMT N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BXMT Real Estate Investment Trusts
- Sector
- CLDX Health Care
- BXMT Real Estate
- Exchange
- CLDX Nasdaq
- BXMT Nasdaq
- Market Cap
- CLDX 2.9B
- BXMT 3.0B
- IPO Year
- CLDX 2008
- BXMT N/A
- Fundamental
- Price
- CLDX $23.55
- BXMT $17.86
- Analyst Decision
- CLDX Buy
- BXMT Buy
- Analyst Count
- CLDX 8
- BXMT 9
- Target Price
- CLDX $64.83
- BXMT $20.36
- AVG Volume (30 Days)
- CLDX 1.1M
- BXMT 1.6M
- Earning Date
- CLDX 11-06-2024
- BXMT 10-23-2024
- Dividend Yield
- CLDX N/A
- BXMT 13.05%
- EPS Growth
- CLDX N/A
- BXMT N/A
- EPS
- CLDX N/A
- BXMT N/A
- Revenue
- CLDX $9,976,000.00
- BXMT N/A
- Revenue This Year
- CLDX N/A
- BXMT N/A
- Revenue Next Year
- CLDX N/A
- BXMT N/A
- P/E Ratio
- CLDX N/A
- BXMT N/A
- Revenue Growth
- CLDX 128.55
- BXMT 1.04
- 52 Week Low
- CLDX $23.49
- BXMT $16.53
- 52 Week High
- CLDX $53.18
- BXMT $23.29
- Technical
- Relative Strength Index (RSI)
- CLDX 29.53
- BXMT 37.92
- Support Level
- CLDX $25.56
- BXMT $18.19
- Resistance Level
- CLDX $28.15
- BXMT $19.38
- Average True Range (ATR)
- CLDX 1.62
- BXMT 0.40
- MACD
- CLDX 0.14
- BXMT -0.07
- Stochastic Oscillator
- CLDX 1.27
- BXMT 1.94
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About BXMT Blackstone Mortgage Trust Inc.
Blackstone Mortgage Trust Inc is a real estate finance company primarily involved in the origination and purchase of senior loans collateralized by commercial properties in North America, Europe, and Australia. The vast majority of the company's asset portfolio is comprised of floating rate loans secured by priority mortgages. These mortgages are mainly derived from office, hotel, and manufactured housing properties. A significant percentage of the collateralized real estate properties are located in New York, California, and the United Kingdom. Blackstone Mortgage Trust is managed by a subsidiary of The Blackstone Group and benefits from the market data provided by its parent company. Nearly all of Blackstone Mortgage Trust's revenue is generated in the form of interest income.